110 related articles for article (PubMed ID: 22609487)
1. Interleukin 6 and C-reactive protein in esophageal cancer.
Groblewska M; Mroczko B; Sosnowska D; Szmitkowski M
Clin Chim Acta; 2012 Oct; 413(19-20):1583-90. PubMed ID: 22609487
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum CRP levels after induction chemoradiotherapy reflect poor treatment response in association with IL-6 in serum and local tumor site in patients with advanced esophageal cancer.
Fujiwara H; Suchi K; Okamura S; Okamura H; Umehara S; Todo M; Shiozaki A; Kubota T; Ichikawa D; Okamoto K; Ochiai T; Kokuba Y; Sonoyama T; Otsuji E
J Surg Oncol; 2011 Jan; 103(1):62-8. PubMed ID: 21031427
[TBL] [Abstract][Full Text] [Related]
3. Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Aoki T; Sugaya M; Miyazawa Y; Hayashi H; Miyazaki S; Ochiai T
J Surg Oncol; 2003 Aug; 83(4):248-52. PubMed ID: 12884238
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein 1059G>C genetic polymorphism influences serum C-reactive protein levels after esophagectomy in patients with thoracic esophageal cancer.
Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Nakatsu T; Saito H; Minamiya Y; Suzuki T; Ogawa J
J Am Coll Surg; 2009 Oct; 209(4):477-83. PubMed ID: 19801321
[TBL] [Abstract][Full Text] [Related]
5. The influence of elevated levels of C-reactive protein and hypoalbuminemia on survival in patients with advanced inoperable esophageal cancer undergoing palliative treatment.
Lindenmann J; Fink-Neuboeck N; Koesslbacher M; Pichler M; Stojakovic T; Roller RE; Maier A; Anegg U; Smolle J; Smolle-Juettner FM
J Surg Oncol; 2014 Nov; 110(6):645-50. PubMed ID: 24975677
[TBL] [Abstract][Full Text] [Related]
6. Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma.
Oka M; Yamamoto K; Takahashi M; Hakozaki M; Abe T; Iizuka N; Hazama S; Hirazawa K; Hayashi H; Tangoku A; Hirose K; Ishihara T; Suzuki T
Cancer Res; 1996 Jun; 56(12):2776-80. PubMed ID: 8665513
[TBL] [Abstract][Full Text] [Related]
7. Respiratory insufficiency related to COPD accelerates systemic inflammation, under-nutrition, and angiogenesis in esophageal malignancies.
Krzystek-Korpacka M; Matusiewicz M; Diakowska D; Grabowski K; Neubauer K; Kustrzeba-Wojcicka I; Terlecki G; Gamian A
Exp Oncol; 2008 Mar; 30(1):75-80. PubMed ID: 18438346
[TBL] [Abstract][Full Text] [Related]
8. Serum level of C-reactive protein may be a marker for proliferation of esophageal carcinoma.
Nozoe T; Matsumata T; Sugimachi K
Hepatogastroenterology; 2000; 47(36):1622-3. PubMed ID: 11149017
[TBL] [Abstract][Full Text] [Related]
9. Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma.
Shimada H; Oohira G; Okazumi S; Matsubara H; Nabeya Y; Hayashi H; Takeda A; Gunji Y; Ochiai T
J Am Coll Surg; 2004 May; 198(5):737-41. PubMed ID: 15110807
[TBL] [Abstract][Full Text] [Related]
10. CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer.
Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Saito H; Minamiya Y; Satoh S; Murata K; Suzuki T; Ogawa J
Ann Surg Oncol; 2009 Sep; 16(9):2479-85. PubMed ID: 19495883
[TBL] [Abstract][Full Text] [Related]
11. [The assessment of acute phase proteins as prognostic factors in patients surgically treated for non-small cell lung cancer].
Kasprzyk M; Dyszkiewicz W; Zwaruń D; Leśniewska K; Wiktorowicz K
Pneumonol Alergol Pol; 2008; 76(5):321-6. PubMed ID: 19003761
[TBL] [Abstract][Full Text] [Related]
12. Serum hyaluronic acid and laminin as potential tumor markers for upper gastrointestinal cancers.
Aghcheli K; Parsian H; Qujeq D; Talebi M; Mosapour A; Khalilipour E; Islami F; Semnani S; Malekzadeh R
Eur J Intern Med; 2012 Jan; 23(1):58-64. PubMed ID: 22153533
[TBL] [Abstract][Full Text] [Related]
13. Higher serum C-reactive protein concentration and hypoalbuminemia are poor prognostic indicators in patients with esophageal cancer undergoing radiotherapy.
Wang CY; Hsieh MJ; Chiu YC; Li SH; Huang HW; Fang FM; Huang YJ
Radiother Oncol; 2009 Aug; 92(2):270-5. PubMed ID: 19195729
[TBL] [Abstract][Full Text] [Related]
14. Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma.
Nozoe T; Saeki H; Sugimachi K
Am J Surg; 2001 Aug; 182(2):197-201. PubMed ID: 11574097
[TBL] [Abstract][Full Text] [Related]
15. Evidence that C-reactive protein or IL-6 are not surrogates for all inflammatory cardiovascular risk factors in hemodialysis patients.
Kaysen GA; Levin NW; Mitch WE; Chapman AL; Kubala L; Eiserich JP
Blood Purif; 2006; 24(5-6):508-16. PubMed ID: 17077623
[TBL] [Abstract][Full Text] [Related]
16. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer.
Hefler-Frischmuth K; Seebacher V; Polterauer S; Tempfer C; Reinthaller A; Hefler L
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329
[TBL] [Abstract][Full Text] [Related]
17. Serum parathyroid hormone-related peptide is associated with systemic inflammation and adverse prognosis in gastroesophageal carcinoma.
Deans C; Wigmore S; Paterson-Brown S; Black J; Ross J; Fearon KC
Cancer; 2005 May; 103(9):1810-8. PubMed ID: 15800880
[TBL] [Abstract][Full Text] [Related]
18. [Clinical value of preoperative serum VEGF, CRP and IL-6 levels in colorectal carcinoma].
Li ZP; Han JQ; Meng XW; Yang YF
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):795-9. PubMed ID: 21163075
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein serum levels are closely associated with lymph node status, but not with prognosis in patients with vulvar cancer.
Six L; Polterauer S; Grimm C; Seebacher V; Tempfer C; Heinze G; Joura E; Reinthaller A; Hefler LA
Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):217-21. PubMed ID: 17459567
[TBL] [Abstract][Full Text] [Related]
20. Serum adiponectin levels in patients with esophageal cancer.
Yildirim A; Bilici M; Cayir K; Yanmaz V; Yildirim S; Tekin SB
Jpn J Clin Oncol; 2009 Feb; 39(2):92-6. PubMed ID: 19116211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]